GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Plus Therapeutics Inc (STU:XMP0) » Definitions » Other Gross PPE

Plus Therapeutics (STU:XMP0) Other Gross PPE : €0.63 Mil (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Plus Therapeutics Other Gross PPE?

Plus Therapeutics's Other Gross PPE for the quarter that ended in Sep. 2024 was €0.63 Mil.

Plus Therapeutics's quarterly Other Gross PPE declined from Mar. 2024 (€0.89 Mil) to Jun. 2024 (€0.81 Mil) and declined from Jun. 2024 (€0.81 Mil) to Sep. 2024 (€0.63 Mil).

Plus Therapeutics's annual Other Gross PPE increased from Dec. 2021 (€1.77 Mil) to Dec. 2022 (€1.94 Mil) but then declined from Dec. 2022 (€1.94 Mil) to Dec. 2023 (€1.85 Mil).


Plus Therapeutics Other Gross PPE Historical Data

The historical data trend for Plus Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plus Therapeutics Other Gross PPE Chart

Plus Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.22 1.91 1.77 1.94 1.85

Plus Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.16 1.85 0.89 0.81 0.63

Plus Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Plus Therapeutics Business Description

Traded in Other Exchanges
Address
4200 Marathon Boulevard, Suite 200, Austin, TX, USA, 78756
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Plus Therapeutics Headlines

No Headlines